Austar Lifesciences (Austar Lifesciences) Price-to-Operating-Cash-Flow : (As of Jun. 07, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Austar Lifesciences Price-to-Operating-Cash-Flow?

As of today (2024-06-07), Austar Lifesciences's share price is $0.005. Austar Lifesciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.02. Hence, Austar Lifesciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Austar Lifesciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 11 years, Austar Lifesciences's highest Price-to-Operating-Cash-Flow Ratio was 245.04. The lowest was 7.99. And the median was 43.78.

AULSF's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 20.46
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Austar Lifesciences's Cash Flow from Operations per share for the six months ended in Dec. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.02.

During the past 11 years, Austar Lifesciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 59.10% per year. The lowest was -12.80% per year. And the median was 23.15% per year.

Austar Lifesciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Austar Lifesciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences Price-to-Operating-Cash-Flow Chart

Austar Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

63.05

50.33

Austar Lifesciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Austar Lifesciences's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Austar Lifesciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Austar Lifesciences's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Austar Lifesciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Austar Lifesciences's Price-to-Operating-Cash-Flow falls into.

Austar Lifesciences Price-to-Operating-Cash-Flow Calculation

Austar Lifesciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.005	/	-0.017
	=

Austar Lifesciences's Share Price of today is $0.005.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austar Lifesciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.02.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Austar Lifesciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Austar Lifesciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Austar Lifesciences (Austar Lifesciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (OTCPK:AULSF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

06118:Hong Kong

Address

No. 1018, Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN

Website

https://www.austar.com.hk

Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.

Austar Lifesciences (Austar Lifesciences) Headlines

No Headlines